|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0021734,
umls-concept:C0027627,
umls-concept:C0030705,
umls-concept:C0151779,
umls-concept:C0205147,
umls-concept:C0443252,
umls-concept:C0677850,
umls-concept:C0746922,
umls-concept:C1280500,
umls-concept:C1706163,
umls-concept:C2697524,
umls-concept:C2700445
|
|
pubmed:issue |
9285
|
|
pubmed:dateCreated |
2001-9-24
|
|
pubmed:abstractText |
Less than half of patients with melanoma that has spread to local draining regional lymph nodes (stage III melanoma) live with no disease for 5 years or longer after surgery. We aimed to see whether interferon alpha-2a increased survival prospects in these patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
358
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
866-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11567700-Adolescent,
pubmed-meshheading:11567700-Adult,
pubmed-meshheading:11567700-Antineoplastic Agents,
pubmed-meshheading:11567700-Chemotherapy, Adjuvant,
pubmed-meshheading:11567700-Child,
pubmed-meshheading:11567700-Child, Preschool,
pubmed-meshheading:11567700-Combined Modality Therapy,
pubmed-meshheading:11567700-Disease-Free Survival,
pubmed-meshheading:11567700-Female,
pubmed-meshheading:11567700-Humans,
pubmed-meshheading:11567700-Infant,
pubmed-meshheading:11567700-Interferon-alpha,
pubmed-meshheading:11567700-Lymph Node Excision,
pubmed-meshheading:11567700-Lymphatic Metastasis,
pubmed-meshheading:11567700-Male,
pubmed-meshheading:11567700-Melanoma,
pubmed-meshheading:11567700-Middle Aged,
pubmed-meshheading:11567700-Quality of Life,
pubmed-meshheading:11567700-Recombinant Proteins
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial.
|
|
pubmed:affiliation |
National Cancer Institute, Via G Venezian 1, 20133, Milan, Italy. who-melanoma@istitutotumori.mi.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
